Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00907595|
Recruitment Status : Withdrawn (unable to recruit subjects for study.Collaborator stopped funding for study as of 3/31/2010)
First Posted : May 22, 2009
Last Update Posted : November 6, 2012
Massachusetts General Hospital
Information provided by (Responsible Party):
Kaloyan Tanev, MD, Massachusetts General Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||March 2010|
|Actual Study Completion Date :||July 2010|
Hurelbrink CB, Lewis SJ, Barker RA. The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease. J Neurol. 2005 Jun;252(6):642-7. Epub 2005 Mar 7.
Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci. 2005 Jan 5;25(1):157-63. Erratum in: J Neurosci. 2005 Apr 13;25(15):3994.